Hypermethylation of Genes Detected in Urine from Ghanaian Adults with Bladder Pathology Associated with Schistosoma haematobium Infection

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhong, Xiaoli ^a   Isharwal, Sumit ^c,f   Naples, Jean M ^b   Shiff, Clive ^b   Veltri, Robert W ^c   Shao, Chunbo ^a   Bosompem, Kwabena M ^d   Sidransky, David ^a   Hoque, Mohammad O ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d University of Ghana   (Ghana)

^e Gono University   (Bangladesh)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARF GENE; ARTICLE; BLADDER DISEASE; BLADDER INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA EXTRACTION; DNA METHYLATION; ECHOGRAPHY; ENDEMIC DISEASE; ETHNICITY; FEMALE; GENE; GHANAIAN; HUMAN; MALE; MGMT GENE; P16 GENE; PILOT STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; QUANTITATIVE ANALYSIS; RARB2 GENE; RASSF1A GENE; RECEIVER OPERATING CHARACTERISTIC; RUNX3 GENE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TIMP3 GENE; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GHANA; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; SCHISTOSOMIASIS HAEMATOBIA; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84875062770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059089     Document Type: Article

References (43)

1. Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl: 12-20.
2. Mostafa MH, Sheweita SA, O'Connor PJ, (1999) Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 12: 97-111.
3. Shiff C, Veltri R, Naples J, Quartey J, Otchere J, et al. (2006) Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. Trans R Soc Trop Med Hyg 100: 847-854.
4. Ibironke OA, Phillips AE, Garba A, Lamine SM, Shiff C, (2011) Diagnosis of Schistosoma haematobium by Detection of Specific DNA Fragments from Filtered Urine Samples. Am J Trop Med Hyg 84: 998-1001.
5. Shiff C, Naples JM, Isharwal S, Bosompem KM, Veltri RW, (2010) Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use? Trans R Soc Trop Med Hyg 104: 3-5.
6. Yoshida T, Kato J, Maekita T, Yamashita S, Enomoto S,et al. (2013) Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association.
7. Koch MW, Metz LM, Kovalchuk O, (2012) Epigenetic changes in patients with multiple sclerosis. Nature reviews Neurology 9: 35-43.
8. Kato S, Lindholm B, Stenvinkel P, Ekstrom TJ, Luttropp K, et al. (2012) DNA hypermethylation and inflammatory markers in incident Japanese dialysis patients. Nephron extra 2: 159-168.
9. Huang FY, Chan AO, Rashid A, Wong DK, Cho CH, et al. (2012) Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1beta activation of nitric oxide production in gastric cancer cells. Cancer 118: 4969-4980.
10. Ushijima T, Hattori N, (2012) Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers. Clinical cancer research: an official journal of the American Association for Cancer Research 18: 923-929.
11. Toyota M, Yamamoto E, (2011) DNA methylation changes in cancer. Progress in molecular biology and translational science 101: 447-457.
12. Ryan JL, Jones RJ, Kenney SC, Rivenbark AG, Tang W, et al. (2010) Epstein-Barr virus-specific methylation of human genes in gastric cancer cells. Infectious agents and cancer 5: 27.
13. Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, et al. (2010) Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer research 70: 1430-1440.
14. Maekawa M, Watanabe Y, (2007) Epigenetics: relations to disease and laboratory findings. Current medicinal chemistry 14: 2642-2653.
15. Gutierrez MI, Siraj AK, Khaled H, Koon N, El-Rifai W, et al. (2004) CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod Pathol 17: 1268-1274.
16. Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, et al. (2006) Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst 98: 996-1004.
17. Jeong P, Min BD, Ha YS, Song PH, Kim IY, et al. (2012) RUNX3 methylation in normal surrounding urothelium of patients with non-muscle-invasive bladder cancer: potential role in the prediction of tumor progression. Eur J Surg Oncol 38: 1095-1100.
18. Knapp DW, (2008) RUNX3 methylation and the potential to predict the behavior of bladder cancer. J Urol 180: 806-807.
19. Wolff EM, Liang G, Cortez CC, Tsai YC, Castelao JE, et al. (2008) RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res 68: 6208-6214.
20. Yan C, Kim YW, Ha YS, Kim IY, Kim YJ, et al. (2012) RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer. J Surg Oncol 105: 425-430.
21. WHO (2000) Ultrasound in Schistosomiasis. A practical guide to the standardized use of ultrasonography for assessment of schistosomiasis-related morbidity. World Health Organization, Geneva TDR/STR/SCH/001.
22. Yosry A, (2006) Schistosomiasis and neoplasia. Contrib Microbiol 13: 81-100.
23. Khurana S, Dubey ML, Malla N, (2005) Association of parasitic infections and cancers. Indian J Med Microbiol 23: 74-79.
24. van Rhijn BW, van der Poel HG, van der Kwast TH, (2005) Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47: 736-748.
25. de Martel C, Franceschi S, (2009) Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 70: 183-194.
26. Schottenfeld D, Beebe-Dimmer J, (2006) Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56: 69-83.
27. Laird PW, (2005) Cancer epigenetics. Hum Mol Genet 14 Spec No 1: R65-76.
28. Maier S, Olek A, (2002) Diabetes: a candidate disease for efficient DNA methylation profiling. J Nutr 132: 2440S-2443S.
29. Zaina S, Lindholm MW, Lund G, (2005) Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? J Nutr 135: 5-8.
30. Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, et al. (2008) CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter 13: 35-41.
31. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, et al. (2006) High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995.
32. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, et al. (2007) Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol 102: 1361-1371.
33. Leung WK, Man EP, Yu J, Go MY, To KF, et al. (2006) Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 12: 3216-3221.
34. Esteller M, Corn PG, Baylin SB, Herman JG, (2001) A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229.
35. Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, et al. (2008) Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev 17: 2786-2794.
36. Liang JF, Zheng HX, Li N, Yin Y, Cheng CX, et al. (2010) Fluorescent microsatellite analysis of urine sediment in patients with urothelial carcinoma. Urologia internationalis 85: 296-303.
37. Serizawa RR, Ralfkiaer U, Steven K, Lam GW, Schmiedel S, et al. (2011) Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events. International journal of cancer Journal international du cancer 129: 78-87.
38. Shirodkar SP, Lokeshwar VB, (2009) Potential new urinary markers in the early detection of bladder cancer. Current opinion in urology 19: 488-493.
39. Mitra AP, Cote RJ, (2009) Molecular pathogenesis and diagnostics of bladder cancer. Annual review of pathology 4: 251-285.
40. Riesz P, Lotz G, Paska C, Szendroi A, Majoros A, et al. (2007) Detection of bladder cancer from the urine using fluorescence in situ hybridization technique. Pathology oncology research: POR 13: 187-194.
41. Bartoletti R, Cai T, Dal Canto M, Boddi V, Nesi G,et al. (2006) Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma. The Journal of urology 175: 2032-2037; discussion 2037.
42. Berger AP, Parson W, Stenzl A, Steiner H, Bartsch G, et al. (2002) Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue. European urology 41: 532-539.
43. Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, et al. (2007) Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer 96: 1278-1283.